ME LINE 02 NIGHT CREAM ETHNIC SKIN 20g
INNOAESTHETICS
Skin careDepigmenting night cream for ethnic skin
Certifications
- Manufactured by Laboratorio Innoaesthetics, S.L.U., a laboratory with GMP Certified production as stated in company information.
- Dermocosmetic/aesthetic product intended for skin depigmentation; not presented as a medicinal product or medical device in the consulted sources.
- Manufactured by Laboratorio Innoaesthetics, S.L.U., a laboratory with GMP Certified production as stated in company information.
- Dermocosmetic/aesthetic product intended for skin depigmentation; not presented as a medicinal product or medical device in the consulted sources.
Depigmenting night cream for ethnic skin
Description
ME-LINE 02 NIGHT CREAM ETHNIC SKIN is a home-use night depigmenting emulsion specifically formulated for Fitzpatrick phototypes IV–VI. It helps improve and delay the appearance of cutaneous hyperpigmentations such as melasma and chloasma by inhibiting tyrosinase and reducing melanin deposits, while its depigmenting and antioxidant ingredients are designed to be well tolerated on ethnic skin.
Bnefits
- Reduces existing hyperpigmentation and melanin deposits in ethnic skin (phototypes IV–VI).
- Helps improve and delay the appearance of melasma, chloasma and other dark spots.
- Inhibits tyrosinase activity, thereby decreasing melanin synthesis.
- Supports epidermal renewal and elimination of pigmented cells.
- Contributes to a more even, clarified and unified skin tone.
- Formulated as a home treatment to complement professional depigmenting protocols.
- Active ingredients selected for good tolerability on darker phototypes.
Indications
- Melasma
- Chloasma
- Facial hyperpigmentation in phototypes IV–VI
- Age spots and dark brown spots on ethnic skin
- Post-inflammatory or diffuse epidermal hyperpigmentation (under professional supervision)
- Maintenance phase following professional ME-LINE depigmenting treatments
Composition
- Pyruvic Acid
- Tranexamic Acid
- Salicylic Acid
- Undecylenoyl Phenylalanine
- Phytic Acid
- Glutathione
Formulation
- Night depigmenting emulsion (cream) for Fitzpatrick phototypes IV–VI
- Dermocosmetic formula combining exfoliating acids, depigmenting agents and antioxidants
- Home-treatment product intended for continuous, medium- to long-term use
Packaging
- 20 g (0.7 oz) airless pump bottle (flacon-pompe airless)
- Primary packaging labeled for home treatment of hyperpigmentation in ethnic skin
- Often referenced with customs/HS code 33049900 for export classification
Usage
- Use in the evening as part of the home treatment protocol, or as directed by a qualified professional.
- After cleansing the facial skin, apply a thin, even layer of the cream over the entire face.
- Massage gently until complete absorption.
- Use every night until the tube is finished, unless otherwise directed by the treating professional.
- Avoid contact with the eyes, mucous membranes and areas of irritated or broken skin.
- Use appropriate daytime photoprotection (high-SPF sunscreen) during the treatment period.
Contraindications
- Specific contraindications are not listed in the publicly available product description; use is recommended under medical or professional supervision, particularly in patients with very sensitive, irritated or compromised skin, and in individuals with known hypersensitivity to any of the ingredients.
Adverse Effects
- No detailed adverse effects are specified in publicly available product information; users should refer to the package leaflet (if provided) and follow professional guidance. As with acid-containing depigmenting products, local irritation, dryness or erythema may occur in susceptible individuals.
Storage Conditions
- Storage conditions are not explicitly detailed on the online product pages; users should follow the instructions on the primary packaging, which typically include keeping the product in a cool, dry place away from direct heat and light and out of reach of children.
Duration
The product must be used for at least 90 days with nightly application; the total treatment duration should be determined by the healthcare or aesthetic professional according to the patient\u2019s response and clinical judgment.
Onset
Improvement is progressive over the treatment period; the exact onset time is not specified by the manufacturer and may vary by individual.
